All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
ARWR real return snapshot: after CPI-U inflation, ARWR returned +402.50% over the past year and +18.93% YTD, with dividends reinvested. Since Dec. 16, 1993, ARWR is down −98.79% in real purchasing-power return, or −12.69%/yr.
Data ending Thu Jun. 18, 2026
| Thu 1993-12-16💬 to Thu 2026-06-18 |
YTD
Return |
1 Year
Return |
||||
|---|---|---|---|---|---|---|
| ARWR × |
+18.93%
2026-06-18 |
+402.50%
2026-06-18 |
||||
| Arrowhead Pharmaceuticals Inc NASDAQ Common Stock | ||||||
| Thu 1993-12-16💬 to Thu 2026-06-18 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| ARWR × |
−98.79%
−12.69%/yr |
−5.29%/yr
(R2=0.116) |
||||
| Arrowhead Pharmaceuticals Inc NASDAQ Common Stock | ||||||
| Thu 1993-12-16💬 to Thu 2026-06-18 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| ARWR × |
$10,000.00
1993-12-16 |
$121.46
2026-06-18 |
||||
| Arrowhead Pharmaceuticals Inc NASDAQ Common Stock | ||||||
| Year | ARWR |
|---|---|
| 2026 (YTD) | +18.93% |
| 2025 | +243.94% |
| 2024 | −40.28% |
| 2023 | −27.00% |
| 2022 | −42.54% |
| 2021 | −19.27% |
| 2020 | +19.34% |
| 2019 | +399.30% |
| 2018 | +231.19% |
| 2017 | +132.51% |
| 2016 | −75.31% |
| 2015 | −17.27% |
| 2014 | −32.49% |
| 2013 | +399.50% |
| 2012 | −49.80% |
| 2011 | −54.53% |
| 2010 | +66.38% |
| 2009 | −43.92% |
| 2008 | −75.68% |
| 2007 | −17.09% |
| 2006 | +0.53% |
| 2005 | −4.88% |
| 2004 | +221.83% |
| 2003 | +227.21% |
| 2002 | −60.92% |
| 2001 | −76.37% |
| 2000 | +20.90% |
| 1999 | −39.13% |
| 1998 | +57.46% |
| 1997 | −68.54% |
| 1996 | −39.51% |
| 1995 | −80.68% |
| 1994 | −55.30% |
| 1993 | −38.89% |
| Thu 1993-12-16💬 to Thu 2026-06-18 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| ARWR × | −98.79% |
−99.97%
2016-12-16 |
||||
| Arrowhead Pharmaceuticals Inc NASDAQ Common Stock | ||||||
| Period ending Thu 2026-06-18 |
1
Year |
2
Years |
3
Years |
5
Years |
10
Years |
|
|---|---|---|---|---|---|---|
| ARWR × | +402.50% |
+224.69% +80.19%/yr |
+109.70% +28.00%/yr |
−22.98% −5.09%/yr |
+921.69% +26.16%/yr |
|
| Arrowhead Pharmaceuticals Inc NASDAQ Common Stock | ||||||
